Insider · CIK 0002011757
Neal Flomenberg
Files at TVGN (Tevogen Bio Holdings Inc.). First filing Oct 18, 2024, latest Mar 17, 2026.
In brief
Neal Flomenberg files SEC Form 4 as officer at TVGN (Tevogen Bio Holdings Inc.). Since Oct 18, 2024, Neal Flomenberg has reported 0 open-market buys worth $0 and 5 open-market sells worth $2.5M, the latest filed on Mar 17, 2026.
A track record needs three past buys with six months of prices behind them; Neal Flomenberg has 0, so none is measured yet.
The newest scored trade: sold $6,635 of TVGN on Mar 10, 2026, filed Mar 17, 2026, scored 15 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $6,635.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TVGN: Tevogen Bio Holdings Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | TVGNsell Tevogen Bio Holdings Inc. | $6,635 972 shares | -1% | +7% from low-89% from high | |
| 28Weak | TVGNsell Tevogen Bio Holdings Inc. | $254k 232,968 shares | -6% | - | |
| 28Weak | TVGNsell Tevogen Bio Holdings Inc. | $232k 211,909 shares | -5% | - | |
| 28Weak | TVGNsell Tevogen Bio Holdings Inc. | $250k 213,817 shares | -5% | - | |
| 45Moderate | TVGNsell Tevogen Bio Holdings Inc. | $1.7M 1,078,600 shares | -20% | - |
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | TVGN Tevogen Bio Holdings Inc. | SOpen-market sale Common Stock | -19 | $7.75 | $147 | 77,893 | Mar 17, 2026 |
| Mar 11, 2026 | TVGN Tevogen Bio Holdings Inc. | SOpen-market sale Common Stock | -452 | $7.26 | $3,282 | 77,441 | Mar 17, 2026 |
| Mar 13, 2026 | TVGN Tevogen Bio Holdings Inc. | SOpen-market sale Common Stock | -501 | $6.40 | $3,206 | 76,940 | Mar 17, 2026 |
| Jun 27, 2025 | TVGN Tevogen Bio Holdings Inc. | AGrant or award Common Stock | +300,000 | $0.00 | $0 | 3,895,608 | Jul 1, 2025 |
| Mar 12, 2025 | TVGN Tevogen Bio Holdings Inc. | SOpen-market sale Common Stock | -232,968 | $1.09 | $254k | 3,595,608 | Mar 14, 2025 |
| Mar 7, 2025 | TVGN Tevogen Bio Holdings Inc. | SOpen-market sale Common Stock | -71,273 | $1.14 | $81k | 3,969,212 | Mar 11, 2025 |
| Mar 10, 2025 | TVGN Tevogen Bio Holdings Inc. | SOpen-market sale Common Stock | -70,384 | $1.09 | $77k | 3,898,828 | Mar 11, 2025 |
| Mar 11, 2025 | TVGN Tevogen Bio Holdings Inc. | SOpen-market sale Common Stock | -70,252 | $1.05 | $74k | 3,828,576 | Mar 11, 2025 |
| Mar 4, 2025 | TVGN Tevogen Bio Holdings Inc. | SOpen-market sale Common Stock | -14,639 | $1.28 | $19k | 4,239,663 | Mar 6, 2025 |
| Mar 5, 2025 | TVGN Tevogen Bio Holdings Inc. | SOpen-market sale Common Stock | -110,659 | $1.21 | $134k | 4,129,004 | Mar 6, 2025 |
| Mar 6, 2025 | TVGN Tevogen Bio Holdings Inc. | SOpen-market sale Common Stock | -88,519 | $1.10 | $97k | 4,040,485 | Mar 6, 2025 |
| Oct 17, 2024 | TVGN Tevogen Bio Holdings Inc. | SOpen-market sale Common Stock | -1,078,600 | $1.62 | $1.7M | 4,254,302 | Oct 18, 2024 |
Questions about Neal Flomenberg
Answered from the filings on this page, as of the latest one.
Is Neal Flomenberg buying or selling?
In the last 12 months Neal Flomenberg reported 0 open-market buys worth $0 and 1 open-market sell worth $6,635 on SEC Form 4; the latest was sold $6,635 of TVGN on Mar 10, 2026. Grants, option exercises and tax withholding are not counted.
How did Neal Flomenberg's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Neal Flomenberg has 0.
Where does Neal Flomenberg file Form 4?
Neal Flomenberg has filed Form 4 at TVGN (Tevogen Bio Holdings Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.